The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Hospira Inc

NYSE: HSP
Last

(U.S.) $87.84

Today's change0.00 0.00%
Updated April 20 4:02 PM EDT. Delayed by at least 15 minutes.
 

Hospira Inc

NYSE: HSP
Last

(U.S.) $87.84

Today's change0.00 0.00%
Updated April 20 4:02 PM EDT. Delayed by at least 15 minutes.

Hospira Inc unchanged

Hospira Inc is unchanged Monday sitting at (U.S.)$87.84. Over the last five days, shares are unchanged, but have gained 43.41% over the last year to date. This security has outperformed the S&P 500 by 91.27% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $87.84
  • High--
  • Low--
  • Bid / Ask(U.S.) $87.01 / (U.S.) $89.84
  • YTD % change+43.41%
  • Volume0
  • Average volume (10-day)1,657,646
  • Average volume (1-month)1,476,994
  • Average volume (3-month)3,167,425
  • 52-week range(U.S.) $42.45 to (U.S.) $88.15
  • Beta0.68
  • Trailing P/E45.03×
  • P/E 1 year forward35.85×
  • Forward PEG2.93×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.95
Updated April 20 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+7.09%

Based on its net profit margin of 7.09%, Hospira Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue1,1271,1511,1361,051
Total other revenue--------
Total revenue1,1271,1511,1361,051
Gross profit394444426383
Total cost of revenue732707710668
Total operating expense1,0879231,036951
Selling / general / administrative191224211186
Research & development99867683
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)64-944014
Other operating expenses, total--------
Operating income40228100100
Interest income (expense), net non-operating-18-19-19-21
Gain (loss) on sale of assets--------
Other--------
Income before tax222048181
Income after tax341556265
Income tax, total-12491917
Net income361597168
Total adjustments to net income--------
Net income before extra. items361597168
Minority interest--------
Equity in affiliates2393
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items361597168
Inc. avail. to common incl. extra. items361597168
Diluted net income361597168
Dilution adjustment00----
Diluted weighted average shares173172170168
Diluted EPS excluding extraordinary itemsvalue per share0.210.920.420.40
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.450.510.600.47